Today, our CEO, Alex Filicevas, Chaired an expert roundtable at the European Parliament in Brussels to Lead the Change in Bladder Cancer. The meeting was hosted by Liesbet Sommen MEP (European People’s Party (EPP), Belgium) and Dr András Kulja MEP (EPP, Hungary), Vice-Chair of the European Parliament’s ENVI Committee and a Medical Doctor by training.
The roundtable was a meeting convening experts to shape an alliance with focused collective action,
The World Bladder Cancer Patient Coalition (WBCPC) is in Hong Kong for the World Cancer Congress 2026, organised by the Union for International Cancer Control (UICC) with the Hong Kong Anti-Cancer Society.
On September 25, 2026, our Executive Director Alex Filicevas spoke in the session “Promoting Shared Decision Making in Cancer Care”, alongside Olivier Exertier, Executive Director, and Margie Hickey, Board of Directors, of the International Kidney Cancer Coalition (IKCC);
When someone is diagnosed with cancer, a patient organisation is often where they turn for information, support and a voice. Five years after the COVID-19 pandemic began, those organisations are still under strain, and patients feel it first. New research from the Global Cancer Coalitions Network (GCCN) shows where the pressure lies and what needs to change.
The World Bladder Cancer Patient Coalition (WBCPC) is in Hong Kong for the World Cancer Congress 2026,
When someone is diagnosed with bladder cancer, one of the first things they do is look for information. Too often, what they find is hard to read, hard to trust or hard to act on. Our latest research looks at why this happens, and what needs to change.
This week, the World Bladder Cancer Patient Coalition is in Hong Kong for the World Cancer Congress 2026, one of the biggest global events on cancer control.
On Public Day of the World Bladder Cancer Patient Forum 2026 in Hong Kong, Adam Lynch, Founder and CEO of BEAT Bladder Cancer Australia, moderated Charting the path to Shared Decision-Making with Melanie Costin (Fight Bladder Cancer), Dr Brian Ho (Hong Kong Urological Association), Mădălina Iamandei (All.Can International), Nicole Dixon (Johnson & Johnson) and Dr Murallitharan Munisamy (National Cancer Society of Malaysia).
On Public Day of the World Bladder Cancer Patient Forum 2026 in Hong Kong, Lauren Pretorius, CEO of Campaigning for Cancer, moderated Designing patient-centric clinical trials, joined by Alessandro Boni, Vice President of Associazione PaLiNUro in Italy, Dr Kenneth Chen, Senior Consultant in Uro-oncology at Singapore General Hospital, and Anjali Malhotra, Senior Vice President of Clinical Operations at ImmunityBio.
Lauren set the terms of the discussion in her opening.
On Public Day of the World Bladder Cancer Patient Forum 2026 in Hong Kong, two members of our Scientific Advisory Board presented Latest developments in bladder cancer research: Prof. Jeremy Teoh, Professor and Assistant Dean (External Affairs) at the Faculty of Medicine, The Chinese University of Hong Kong and Vice Chair of the Board, and Dr Makarand Khochikar, Head of Urology and Urologic Oncology at KIMS Hospital,
Advocates Day closed the way it began: with the room doing the work together. The final session, “Shared evidence & impact: Shaping our next patient and carer survey,” used a World Café format, four tables, three short rounds, and members moving between them, to help shape the next chapter of WBCPC’s research.
Why now
Alex Filicevas, Executive Director of WBCPC, opened with a look back at the Coalition’s 2023 Global Patient and Carer Survey: nearly 1,200 respondents across 45 countries,
Conflict is not a sign something has gone wrong. It’s simply what happens whenever people with different needs, beliefs and backgrounds try to work toward the same goal. That was the reassuring starting point for “Conflict management within an organisation” a workshop on Advocates Day of the World Bladder Cancer Patient Forum 2026 in Hong Kong, led by Eric Sampson, Partner at Dramatic Difference.
Eric opened with a personal note: his own mother was successfully treated for bladder cancer,
No organisation, however small, has to do everything alone. That was the starting point for “Building collaboration and partnerships,” a workshop on Advocates Day of the World Bladder Cancer Patient Forum 2026 in Hong Kong, led by Adam Lynch, CEO of BEAT Bladder Cancer Australia, and Mădălina Iamandei, Executive Director of All.Can International, the multi-stakeholder cancer care coalition that WBCPC itself belongs to.
Why partnerships matter more than ever
Mădălina opened with a fact worth remembering: All.Can now spans 18 national coalitions and around 50 member organisations,
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
